(Q33756784)

29 July 2017

Does levodopa alter depression and psychopathology in Parkinsonism patients? (English)

1 reference

29 July 2017

1 reference

1 reference

parkinsonian syndrome

1 reference

Marsh GG

1

1 reference

PubMed ID

4149286

29 July 2017

Markham CH

series ordinal

2

1 reference

PubMed ID

4149286

29 July 2017

language of work or name

English

0 references

publication date

1 December 1973

1 reference

Journal of Neurology, Neurosurgery and Psychiatry

29 July 2017

1 reference

29 July 2017

36

1 reference

29 July 2017

6

1 reference

29 July 2017

925-935

1 reference

Treatment of Parkinsonism With Levodopa

29 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1083592

Reversal of central anticholinergic syndrome in man by physostigmine

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1083592

Psychic Effects in Patients Treated With Levodopa

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1083592

Parkinsonism, L-dopa and mental depression

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1083592

Treatment of parkinsonism with L-dopa (study of 105 patients)

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1083592

Psychiatric aspects in Parkinsonism treated with L-dopa

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1083592

One to two year treatment of Parkinson's disease with levodopa

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1083592

Treatment of Parkinsonism with Laevo-Dopa

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1083592

Levodopa's awakening effect on patients with Parkinsonism

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1083592

Changes in MMPI scale scores and an index of psychopathology following unilateral temporal lobectomy for epilepsy.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1083592

Depressive symptoms in Parkinson patients referred for thalamotomy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1083592

Mental symptoms in Parkinsonian patients treated with L-dopa.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1083592

Effects of L-dopa in patients with dementia.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1083592

L-dopa in postencephalitic parkinsonism.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1083592

Modification of Parkinsonism--chronic treatment with L-dopa

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1083592

Levodopa and Schizophrenia

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1083592

Treatment of Parkinson's syndrome with L dihydroxyphenylalanine (levodopa).

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1083592

L-Dopa (L-3,4-dihydroxyphenylanine)--its clinical effects in parkinsonism

30 October 2018

1 reference

12 December 2020

DEPRESSION DURING L-DOPA TREATMENT

1 reference

12 December 2020

L-dopa, parkinsonism, and depression.

1 reference

12 December 2020

1 reference

12 December 2020

Another look at MMPI profile types in multiple sclerosis

1 reference

12 December 2020

An index of psychopathology (Ip) derived from clinicians' judgments of MMPI profiles

1 reference

12 December 2020

An abbreviation of the wais for clinical use

1 reference

12 December 2020

Identifiers

DOI

10.1136/JNNP.36.6.925

1 reference

29 July 2017

1 reference

29 July 2017

1 reference

PubMed ID

4149286